Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) Q3 2025 Earnings Call Transcript November 12, 2025 Acurx Pharmaceuticals, Inc.

Continued advancement toward Phase 2/3 clinical trial initiation, on track for the first half of 2026New preclinical data demonstrated SIL204’s ...

Q3 2025 Earnings Call November 11, 2025 10:00 AM ESTCompany ParticipantsPeter Hoetzinger - Vice Chairman, Co-CEO ...

Q3 2025 Earnings Call November 12, 2025 4:30 PM ESTCompany ParticipantsMiranda Peto BenvenutiPeter Altman - CEO, President ...

Rumble Inc. (Nasdaq: RUM) ("Rumble" or the "Company"), the video-sharing platform and cloud services provider, today announced financial results for the fiscal quarter ended September 30, 2025. Q3 ...

Continued advancement toward Phase 2/3 clinical trial initiation, on track for the first half of 2026 New preclinical data demonstrated SIL204's exceptional efficacy across multiple human cancer cell ...

Dorel Juvenile delivers resilient third quarter financial results amid market challenges Dorel Home restructuring on planNew financing arrangements in place strengthen Company's financial position MON ...

Nebius Group N.V. (NASDAQ: NBIS), a leading AI infrastructure company, today announced its unaudited financial results for the third quarter ended September 30, 2025.

The U.S. clinical trial imaging market size is calculated at USD 748.09 million in 2025 and is expected to reach around USD 1675.4 million by 2034, growing at a CAGR of 9.37% for the forecasted period ...

Toledo International Inc. (NYSE: MTD) today announced third quarter results for 2025. Provided below are the highlights: ...

Revenue Increases to $18.6 Million, up 8% Y/Y Delivers Cash Flow from Operations of $0.6 million and Adjusted EBITDA of $1.1 million AI Teaching Assistant Enters Early Access for Select ...

Metso has introduced a redefined OKTOP® Conditioner series aimed at boosting flotation efficiency by improving slurry preparation, reagent distr ...